Investor Relations News Releases

Revenue increased 3.5% to $466.4 million, compared to Q1 2022 Gross margin decreased 0.2% to $144.5 million, compared to Q1 2022 Net loss was $32.0 million, compared to net income of $25.3 million in Q1 2022 Adjusted EBITDA decreased 25.0% to $28.5 million, compared to Q1 2022 Affirms previously

ATLANTA, April 24, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 11, 2023, to be followed by a conference call at 10:00 a.m.

Revenue increased 9.0% to $451.1 million, compared to Q4 2021 Gross margin increased 3.5% to $128.8 million, compared to Q4 2021 Net loss was $237.8 million, compared to net loss of $126.2 million in Q4 2021 Adjusted EBITDA decreased 35% to $29.7 million, compared to Q4 2021 ATLANTA, March 16, 2023

ATLANTA, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 16, 2023, to be followed by a conference call at 10 a.m.